Judge denies reconsideration of class certification in Skelaxin case
MLex Summary: US District Judge Curtis L. Collier has denied indirect purchasers’ motion for reconsideration of an order denying class certification in their case alleging King Pharmaceuticals and Mutual Pharmaceutical conspired to delay generic Skelaxin....To view the full article, register now.
Already a subscriber? Click here to view full article